IR OROS Paliperidone
Showing 1 - 25 of 970
Prevalence of IR in Overweight and Obese Adolescents
Not yet recruiting
- Insulin Resistance
- Blood Tests; Serum Fasting Insulin and Glucose
- (no location specified)
Apr 11, 2023
Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)
Not yet recruiting
- Schizophrenia
- +6 more
- (no location specified)
Sep 27, 2023
Insulin Resistance in Egyptian Patients With Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Insulin Resistance
- treatment of insulin resistance with appropriate modality according to each patient
- (no location specified)
Aug 28, 2023
Disease Characteristics of IR-CAD: a Case-control Study
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Protocol-defined Examinations
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 17, 2023
Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)
Not yet recruiting
- Healthy Volunteers
- BMS-986419 DR Capsule
- BMS-986419 IR Tablet
- (no location specified)
Jul 20, 2023
Visceral Fat in type2diabetic Patients and Its Relation to
Enrolling by invitation
- Visceral Fat
- Insulin Resistance
-
Sohag, EgyptMahmoud Soliman
Oct 31, 2023
Triglyceride Glucose Index and HOMA IR as Predictors of Vascular
Not yet recruiting
- Type 2 Diabetes Mellitus
- triglyceride glucose index and HOMA IR
- (no location specified)
Jan 20, 2023
Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg
Not yet recruiting
- Healthy Participants
- Treatment A: Emraclidine 30mg IR tablets (reference)
- +3 more
-
Overland Park, KansasOverland Park, Kansas
Jun 28, 2023
Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,
Not yet recruiting
- Non Muscle Invasive Bladder Cancer
- +3 more
- Cretostimogene Grenadenorepvec
- n-dodecyl-B-D-maltoside
- (no location specified)
Oct 30, 2023
Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose
Not yet recruiting
- Long COVID
- +2 more
- Adipose Tissue Biopsy
- Steady State Plasma Glucose (SSPG) Test
-
Palo Alto, California
- +1 more
Apr 27, 2023
Cervicogenic Headache Trial in El-Sheikh Zayed City (Shock Wave Therapy, US, TENS, IR and exercises.)
Completed
- Cervicogenic Headache
- Shock Wave Therapy
- US, TENS, IR and exercises.
-
El-Sheikh Zayed City, Giza, EgyptOctober 6 University
Jul 3, 2023
Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)
Completed
- Ulcerative Colitis
- NX-13 250mg IR
- +3 more
-
Huntsville, Alabama
- +30 more
Jan 6, 2023
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023
Sleep and IR in Transgender Adolescents
Not yet recruiting
- Sleep Disorder
- +2 more
- (no location specified)
Aug 3, 2022
Obesity, Morbid, Insulin Resistance Trial in Toronto (Fecal filtrate from 150 g stool from healthy lean donors, Fecal filtrate
Active, not recruiting
- Obesity, Morbid
- Insulin Resistance
- Fecal filtrate from 150 g stool from healthy lean donors
- Fecal filtrate from 150 g of the recipient's own stool
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 1, 2022
Refractive Errors Trial in Sydney, Athens (UV fs-Laser, IR fs-Laser, LASIK)
Not yet recruiting
- Refractive Errors
- UV fs-Laser
- +2 more
-
Sydney, New South Wales, Australia
- +1 more
Aug 28, 2023
Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People Trial in Lille (IR Reflexotherapy, Dietary
Terminated
- Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People
- IR Reflexotherapy
- Dietary care
-
Lille, Nord, FranceNutrInvest - Institut Pasteur de Lille
Dec 6, 2022
Insulin Resistance Trial in Madison (Oral Glucose Tolerance Test, 3 Tesla MRI, Intravenous Catheter)
Completed
- Insulin Resistance
- Oral Glucose Tolerance Test
- +3 more
-
Madison, WisconsinUniversity of Wisconsin-Madison
Aug 3, 2022
Rheumatoid Arthritis Trial (Iguratimod combined with Tofacitinib;)
Not yet recruiting
- Rheumatoid Arthritis
- Iguratimod combined with Tofacitinib;
- (no location specified)
Mar 26, 2023
Healthy Participants Trial in Ruddington (ALXN2050 MR Prototype Tablet, ALXN2050 Immediate Release (IR) Tablet, ALXN2050 MR
Not yet recruiting
- Healthy Participants
- ALXN2050 MR Prototype Tablet
- +2 more
-
Ruddington, Nottinghamshire, United KingdomQuotient Science Ltd
Mar 13, 2023
Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)
Completed
- Advanced Parkinson's Disease
-
Little Rock, Arkansas
- +10 more
May 11, 2022